Novartis Ag NVS
NYSE NVS
$138.30 +0.82 (+0.60%)
As of: Sep 10, 2026 · 11:42 AM EDT

Novartis Ag (NVS) Debt Ratio (2009 - 2026)

Novartis Ag's (NVS) quarterly Debt Ratio came in at 0.08 in Q2 2026, down 1.34% year-over-year from 0.08 in Q2 2025, and up 22.27% quarter-over-quarter from 0.06 in Q1 2026.

Analysis

Novartis Ag (NVS) Debt Ratio (2009 - 2026) Analysis & Trends

Novartis Ag has disclosed Debt Ratio across 18 years of filings, most recently posting 0.08 for Q2 2026.

  • In Q2 2026, Debt Ratio fell 1.34% year-over-year to 0.08; the TTM figure through Jun 2026 stood at 0.08 (down 1.34% YoY), while the FY2025 annual figure was 0.06, down 34.74% from the prior year.
  • Debt Ratio came in at 0.08 for Q2 2026 at Novartis Ag, up from 0.06 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.09 in Q1 2024 to a low of 0.05 in Q3 2023.
  • Average Debt Ratio over 5 years is 0.07, with a median of 0.07 recorded in 2023.
  • Year-over-year, Debt Ratio plunged 35.95% in 2022 and soared 42.39% in 2024.
  • Over 5 years, Debt Ratio stood at 0.06 in 2022, then increased by 17.6% to 0.07 in 2023, then climbed by 27.58% to 0.09 in 2024, then tumbled by 34.74% to 0.06 in 2025, then surged by 38.72% to 0.08 in 2026.
  • Per Business Quant data, the three most recent Debt Ratio figures were 0.08 in Q2 2026, 0.06 in Q1 2026, and 0.06 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 641.22 Bn 620.47 Bn 17.26 Bn 0.30
2 AbbVie 446.28 Bn 439.71 Bn 12.70 Bn 0.52
3 Merck 357.56 Bn 350.42 Bn 12.21 Bn 0.42
4 Novartis Ag 268.11 Bn 260.42 Bn 11.24 Bn 0.08
5 Pfizer 156.86 Bn 145.17 Bn 10.94 Bn 0.31
6 Sanofi 52.10 Bn 44.72 Bn 10.79 Bn 0.17
7 Revolution Medicines 43.01 Bn 43.01 Bn - -
8 Incyte 24.82 Bn 20.28 Bn 1.57 Bn 0.00
9 United Therapeutics 21.39 Bn 18.73 Bn 683.80 Mn -
10 Neurocrine Biosciences 15.92 Bn 15.53 Bn 935.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.08
Mar 31, 2026 0.06
Dec 31, 2025 0.06
Sep 30, 2025 0.07
Jun 30, 2025 0.08
Mar 31, 2025 0.08
Dec 31, 2024 0.09
Sep 30, 2024 0.06
Jun 30, 2024 0.08
Mar 31, 2024 0.09
Dec 31, 2023 0.07
Sep 30, 2023 0.05
Jun 30, 2023 0.07
Mar 31, 2023 0.06
Dec 31, 2022 0.06
Sep 30, 2022 0.06
Jun 30, 2022 0.06
Mar 31, 2022 0.05
Dec 31, 2021 0.05
Sep 30, 2021 0.08